Clinical Observation of Botulinum Toxin A Treatment in the Treatment of Rosacea

Last updated: February 20, 2024
Sponsor: Nanjing First Hospital, Nanjing Medical University
Overall Status: Active - Recruiting

Phase

N/A

Condition

Rosacea

Treatment

Botulinum Toxin Type A Injection [Botox]

Clinical Study ID

NCT06282679
KY20220701-03
  • Ages 18-60
  • All Genders
  • Accepts Healthy Volunteers

Study Summary

the goal of this study is to study the clinical efficacy and safety of botox in the treatment of rosacea.

Eligibility Criteria

Inclusion

Inclusion Criteria

  • Meeting the diagnostic criteria of mild to moderate erythema telangiectasis rosetteacne;
  • more than 18 years old;
  • to obey the rules of the treatment in the study, and can be followed up for 12 weeks;
  • informed consent;

Exclusion

Exclusion Criteria:

  • Had received facial cosmetic surgery or botulinum toxin treatment within 6 monthsbefore this treatment;
  • due to systemic diseases such as autoimmune diseases or menopause facial flush;
  • had allergies botulinum toxin;
  • pregnant or breastfeeding;
  • other facial skin or oral disease therapy, including research before 4 weeks rose acneaccept other treatment;
  • With basic neuromuscular diseases (such as myasthenia gravis, amyotrophic lateralsclerosis, etc.);
  • All landowners 4 weeks before the study whether any oral aminoglycoside drugs,benzodiazepines drugs or muscle relaxants; .Was removed during treatment observationdata is not complete, incomplete treatment and patients can't take medication asprescribed.

Study Design

Total Participants: 30
Treatment Group(s): 1
Primary Treatment: Botulinum Toxin Type A Injection [Botox]
Phase:
Study Start date:
April 01, 2022
Estimated Completion Date:
June 28, 2024

Study Description

The main objective is to collect patients and then use different injection volumes of botulinum toxin intradermal injection for the treatment of rosacea erythema telangiectasia, and then to evaluate the clinical efficacy and safety of the treatment.

Connect with a study center

  • Jie Dai

    Nanjing, Jiangsu 210006
    China

    Active - Recruiting

Not the study for you?

Let us help you find the best match. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.